Kodiak Sciences

Yahoo Finance • 12 days ago

These Were the Russell 2000 Stocks That Dominated In Q3 2025

The small cap-focused Russell 2000 index has spent years lagging behind the larger S&P 500 and Nasdaq 100 indexes, but in third-quarter 2025 it took a big leap back to parity with large caps. Thanks to interest-rate-cut bets and optimism... Full story

Yahoo Finance • 18 days ago

Kodiak gains as Barclays upgrades on Roche data for eye disease drug

[Wall Street sign in Lower Manhattan, NYC] georgeclerk Shares of Kodiak Sciences (NASDAQ:KOD [https://seekingalpha.com/symbol/KOD]) climbed on Thursday after Barclays upgraded the eye drug developer, citing a positive read-through from a... Full story

Yahoo Finance • 2 months ago

JPMorgan upgrades Kodiak Sciences stock rating to Neutral from Underweight

Investing.com - JPMorgan has upgraded Kodiak Sciences Inc. (NASDAQ:KOD) from Underweight to Neutral and established a price target of $15.00 for December 2026. The stock has shown remarkable momentum, delivering a 238% return over the past... Full story

Yahoo Finance • 2 months ago

Mali's mines minister visits Kodal Minerals' Bougouni lithium site

BAMAKO - Mali’s Minister of Mines, Professor Amadou Keita, and Bougouni Regional Governor General Ousmane Wele visited Kodal Minerals ’ (AIM:LON:KOD) Bougouni Lithium Project last week to review operations, according to a company press re... Full story

Yahoo Finance • 3 months ago

Kodal Minerals directors adjust shareholdings after warrant exercise

LONDON - Kodal Minerals Plc (AIM:LON:KOD) announced Thursday that three of its directors have adjusted their shareholdings following the exercise of warrants previously announced on July 2. CEO Bernard Aylward purchased 20,000,000 ordin... Full story

Yahoo Finance • 3 months ago

Kodal Minerals signs off-take agreement for Mali lithium project

LONDON - Kodal Minerals Plc (AIM:LON:KOD) announced Monday it has signed a four-year off-take agreement for spodumene concentrate produced at its Bougouni Lithium Project in southern Mali. The agreement between Les Mines de Lithium de B... Full story

Yahoo Finance • 2 years ago

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, y... Full story

Yahoo Finance • 2 years ago

Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

PALO ALTO, Calif., Sept. 8, 2023 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases... Full story

Yahoo Finance • 3 years ago

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

PALO ALTO, Calif., Aug. 5, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases,... Full story

Yahoo Finance • 3 years ago

Stock rebound uncertain for U.S. biotechs as risks multiply for investors

U.S. biotechs and other health care stocks accounted for about 11% of all losses in U.S. equity values during the five-month period analyzed by The Business Journals.... Full story